QR код

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter

Aim. To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibril­lation and flutter (AF/AFL).Material and methods. Fifty five patients (mean age, 65±11 years) with paroxysmal AF/AFL were included. All patients underwent a...

Бүрэн тодорхойлолт

-д хадгалсан:
Үндсэн зохиолчид: D. A. Gagloeva, Kh. M. Dzaurova, M. A. Zelberg, N. Yu. Mironov, Yu. A. Yuricheva, S. F. Sokolov, M. A. Krymukova, A. I. Salpagarova, L. O. Dulaev, D. V. Pevzner, S. P. Golitsyn
Формат: Artigo
Хэл сонгох:Russo
Хэвлэсэн: «SILICEA-POLIGRAF» LLC 2023-05-01
Цуврал:Кардиоваскулярная терапия и профилактика
Нөхцлүүд:
atrial fibrillation
paroxysmal type
refralon
amiodarone
chemical cardioversion
class iii antiarrhythmic drugs
Онлайн хандалт:https://cardiovascular.elpub.ru/jour/article/view/3527
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс